Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125481061 | 12548106 | 1 | I | 20160204 | 20160708 | 20160712 | 20160712 | EXP | PHHY2016BR095212 | NOVARTIS | 85.40 | YR | M | Y | 80.00000 | KG | 20160712 | MD | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125481061 | 12548106 | 1 | PS | EXELON | RIVASTIGMINE TARTRATE | 1 | Oral | 20823 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125481061 | 12548106 | 1 | Memory impairment |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125481061 | 12548106 | DE |
| 125481061 | 12548106 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125481061 | 12548106 | Cerebrovascular accident | |
| 125481061 | 12548106 | Death | |
| 125481061 | 12548106 | Hemiplegia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |